South Korea's impeached President Yoon Suk Yeol will not attend the opening hearing of his trial, which aims to determine whether he will be removed from office or reinstated. Yonhap News Agency reported the development on Sunday, citing a statement from Yoon’s legal representative.
The Constitutional Court has scheduled the first hearing in this high-profile trial, which has drawn significant public and international attention. President Yoon’s impeachment stems from allegations of misconduct, sparking nationwide debates about his leadership and the political future of South Korea.
According to legal procedures, Yoon is not required to attend the initial hearing, and his legal team has opted to represent him in court instead. This decision has fueled speculation about the defense strategy and its potential implications for the case's outcome.
The trial will serve as a pivotal moment in South Korea’s political landscape, as the court weighs evidence and testimony to decide Yoon's fate. Public opinion remains deeply divided, with some calling for his removal and others advocating for his reinstatement.
If the court upholds the impeachment, Yoon will be permanently removed from office, triggering a new presidential election. Alternatively, a dismissal of the case would restore him to power, allowing him to complete his term.
As the trial progresses, it is expected to capture widespread attention domestically and internationally, with far-reaching consequences for South Korea's democracy and governance.
This case underscores the growing global focus on political accountability and the role of constitutional courts in resolving disputes involving national leaders.


Trump’s Inflation Claims Clash With Voters’ Cost-of-Living Reality
Trump Endorses Japan’s Sanae Takaichi Ahead of Crucial Election Amid Market and China Tensions
Trump Allegedly Sought Airport, Penn Station Renaming in Exchange for Hudson River Tunnel Funding
South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns
Jack Lang Resigns as Head of Arab World Institute Amid Epstein Controversy
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Iran–U.S. Nuclear Talks in Oman Face Major Hurdles Amid Rising Regional Tensions
U.S. to Begin Paying UN Dues as Financial Crisis Spurs Push for Reforms
Norway Opens Corruption Probe Into Former PM and Nobel Committee Chair Thorbjoern Jagland Over Epstein Links
Netanyahu to Meet Trump in Washington as Iran Nuclear Talks Intensify
Trump Signs Executive Order Threatening 25% Tariffs on Countries Trading With Iran
India–U.S. Interim Trade Pact Cuts Auto Tariffs but Leaves Tesla Out
U.S. Lawmakers to Review Unredacted Jeffrey Epstein DOJ Files Starting Monday
Japan Election 2026: Sanae Takaichi Poised for Landslide Win Despite Record Snowfall
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
Pentagon Ends Military Education Programs With Harvard University 



